{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:59:16Z","timestamp":1789675156622,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FOREUM Foundation for Research in Rheumatology"},{"name":"IRCCS Istituto Giannina Gaslini"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["260353"],"award-info":[{"award-number":["260353"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Little is known about the disposition to autoimmune diseases (ADs) among children diagnosed with JIA. In this study, we provide a comprehensive overview of the prevalence of and factors associated with ADs in parents of children with juvenile idiopathic arthritis (JIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Prevalence rates of ADs and 95% Poisson confidence intervals were calculated for parents of JIA patients from the international Pharmachild registry and compared with general population prevalence rates as reported in the literature. Demographic, clinical and laboratory features were compared between JIA patients with and without a family history of AD using \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      and Mann-Whitney\n                      <jats:italic>U<\/jats:italic>\n                      tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eight thousand six hundred seventy three patients were included and the most common familial ADs were psoriasis, autoimmune thyroid disease, rheumatoid arthritis and ankylosing spondylitis. The prevalence of several ADs was higher in parents of the included JIA patients than in the general population. Clinical Juvenile Arthritis Disease Activity Scores at study entry and last follow-up were not significantly different between patients with (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091231) and without a family history of AD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097442). Factors associated with familial AD were older age at JIA onset (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), Scandinavian residence (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), enthesitis-related arthritis, psoriatic arthritis and undifferentiated arthritis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01), ANA positivity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) and HLA-B27 positivity (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Familial AD proves to be a risk factor for JIA development and certain diseases should therefore not be overlooked during family health history at the diagnosis stage. A family history of AD is associated with the JIA category but does not influence the severity or disease course.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12969-022-00762-y","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T07:03:38Z","timestamp":1668755018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8766-6694","authenticated-orcid":false,"given":"Joeri W.","family":"van Straalen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytze","family":"de Roock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Giancane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Alexeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Koskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mesa-del-Castillo Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Civino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Montin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Paediatric Rheumatology International Trials Organisation (PRINTO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","unstructured":"Martini A, Lovell DJ, Albani S, et al. Juvenile idiopathic arthritis. Nat Rev Dis Primers. 2022;8(1):5. Published 2022 Jan 27. https:\/\/doi.org\/10.1038\/s41572-021-00332-8.","DOI":"10.1038\/s41572-021-00332-8"},{"key":"762_CR2","first-page":"1","volume":"11","author":"J C\u00e1rdenas-Rold\u00e1n","year":"2013","unstructured":"C\u00e1rdenas-Rold\u00e1n J, Rojas-Villarraga A, Anaya J-M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med BioMed Central. 2013;11:1\u201322.","journal-title":"BMC Med BioMed Central"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.autrev.2012.02.002","volume":"11","author":"JM Anaya","year":"2012","unstructured":"Anaya JM. Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev Elsevier. 2012;11:781\u20134.","journal-title":"Autoimmun Rev Elsevier"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-016-0075-7","volume":"14","author":"S Prahalad","year":"2016","unstructured":"Prahalad S, McCracken CE, Ponder LA, Angeles-Han ST, Rouster Stevens KA, Vogler LB, et al. Familial autoimmunity in the childhood arthritis and rheumatology research alliance registry. Pediatr Rheumatol. 2016;14:1\u20137 2016 141. BioMed Central.","journal-title":"Pediatr Rheumatol"},{"key":"762_CR5","first-page":"569","volume":"23","author":"M Khani","year":"2013","unstructured":"Khani M, Ziaee V, Moradinejad M-H, Parvaneh N. The effect of positive family history of autoimmunity in juvenile idiopathic arthritis characteristics; a case control study. Iran J Pediatr. 2013;23:569 Kowsar Medical Institute.","journal-title":"Iran J Pediatr"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/1756-185X.14167","volume":"24","author":"SM Al-Mayouf","year":"2021","unstructured":"Al-Mayouf SM, Alrasheedi A, Almsellati I, Hashad S, Khawaja K, Abdwani R, et al. Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: impact on clinical characteristics, disease activity status and disease damage. Int J Rheum Dis. John Wiley & Sons, Ltd. 2021;24:1080\u20135.","journal-title":"Int J Rheum Dis"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/art.10370","volume":"46","author":"S Prahalad","year":"2002","unstructured":"Prahalad S, Shear E, Thompson S, Giannini E, Glass D. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46:1851\u20136.","journal-title":"Arthritis Rheum"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-017-0373-9","volume":"43","author":"E Tronconi","year":"2017","unstructured":"Tronconi E, Miniaci A, Pession A. The autoimmune burden in juvenile idiopathic arthritis. Ital J Pediatr. 2017;43:1\u20136.","journal-title":"Ital J Pediatr"},{"key":"762_CR9","first-page":"88","volume":"37","author":"C Huang","year":"2004","unstructured":"Huang C, Yang Y, Chiang B. Different familial association patterns of autoimmune diseases between juvenile-onset systemic lupus erythematosus and juvenile rheumatoid arthritis. J Microbiol Immunol Infect. 2004;37:88\u201394.","journal-title":"J Microbiol Immunol Infect"},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/art.1780400822","volume":"40","author":"LM Pachman","year":"1997","unstructured":"Pachman LM, Hayford JR, Hochberg MC, Pallansch MA, Chung A, Daugherty CD, et al. New-onset juvenile dermatomyositis. Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum. 1997;40:1526\u201333 John Wiley & Sons, Ltd.","journal-title":"Arthritis Rheum"},{"key":"762_CR11","first-page":"767","volume-title":"Diabetes, coeliac disease, multiple sclerosis and chronic arthritis in first-degree relatives of patients with juvenile idiopathic arthritis","author":"H Pohjankoski","year":"2012","unstructured":"Pohjankoski H, Kautiainen H, Kotaniemi K, Korppi M, Savolainen A. Diabetes, coeliac disease, multiple sclerosis and chronic arthritis in first-degree relatives of patients with juvenile idiopathic arthritis, vol. 101: Acta Paediatr; 2012. p. 767\u201371. John Wiley & Sons, Ltd"},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","volume":"20","author":"J Swart","year":"2018","unstructured":"Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva \u0415, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. 2018;20:285.","journal-title":"Arthritis Res Ther"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2352-4642(19)30027-6","volume":"3","author":"A Consolaro","year":"2019","unstructured":"Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Heal. 2019;3:255\u201363.","journal-title":"Lancet Child Adolesc Heal"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart JF, EHP VD, Wulffraat NM, De Roock S. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77:336\u201342\u00a0","journal-title":"Ann Rheum Dis"},{"key":"762_CR15","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3899\/jrheum.091474","volume":"37","author":"G Filocamo","year":"2010","unstructured":"Filocamo G, Dav\u00ec S, Pistorio A, Bertamino M, Ruperto N, Lattanzi B, et al. Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis. J Rheumatol. 2010;37:1534\u201341.","journal-title":"J Rheumatol"},{"key":"762_CR16","doi-asserted-by":"publisher","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. Published 2020 May 28. https:\/\/doi.org\/10.1136\/bmj.m1590.","DOI":"10.1136\/bmj.m1590"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MPJ Vanderpump","year":"2011","unstructured":"Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39\u201351.","journal-title":"Br Med Bull"},{"key":"762_CR18","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2020","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2020;41:863\u201377 2020 415 Springer.","journal-title":"Rheumatol Int"},{"key":"762_CR19","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/acr.22831","volume":"68","author":"C Stolwijk","year":"2016","unstructured":"Stolwijk C, Onna M v, Boonen A, Tubergen A v. Global prevalence of Spondyloarthritis: a systematic review and Meta-regression analysis. Arthritis Care Res (Hoboken). 2016;68:1320\u201331 John Wiley & Sons, Ltd.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769\u201378.","journal-title":"Lancet"},{"key":"762_CR21","doi-asserted-by":"publisher","unstructured":"Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112-7. https:\/\/doi.org\/10.1016\/j.jbspin.2013.09.003.","DOI":"10.1016\/j.jbspin.2013.09.003"},{"key":"762_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2458-12-204","volume":"12","author":"T To","year":"2012","unstructured":"To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.","journal-title":"BMC Public Health"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Fard HH, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Heal Promot Perspect. 2020;10:98 Tabriz University of Medical Sciences.","journal-title":"Heal Promot Perspect"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology Oxford. 2017;56:1945\u201361.","journal-title":"Rheumatology Oxford"},{"key":"762_CR25","first-page":"163806","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, et al. The prevalence of Vitiligo: a Meta-analysis. PLoS One. Public Library of Science. 2016;11:163806.","journal-title":"PLoS One"},{"key":"762_CR26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","volume":"16","author":"P Singh","year":"2018","unstructured":"Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823\u2013836.e2 WB Saunders.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"762_CR27","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Aparicio \u00c1, Garc\u00eda de Y\u00e9benes MJ, Ot\u00f3n T, Mu\u00f1oz-Fern\u00e1ndez S. Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis. Ophthalmic Epidemiol. 2021;28(6):461-8. https:\/\/doi.org\/10.1080\/09286586.2021.1882506.","DOI":"10.1080\/09286586.2021.1882506"},{"key":"762_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","volume":"18","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, et al. Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18:269\u201385.","journal-title":"Lancet Neurol"},{"key":"762_CR29","doi-asserted-by":"publisher","unstructured":"Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527-34. https:\/\/doi.org\/10.1097\/MCP.0000000000000715.","DOI":"10.1097\/MCP.0000000000000715"},{"key":"762_CR30","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:1983\u20139 BMJ Publishing Group Ltd.","journal-title":"Ann Rheum Dis"},{"key":"762_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","volume":"51","author":"P Efthimiou","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still\u2019s disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021;51:858\u201374 WB Saunders.","journal-title":"Semin Arthritis Rheum"},{"key":"762_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/joim.12395","volume":"278","author":"L Wang","year":"2015","unstructured":"Wang L, Wang F-S, Gershwin ME. Human autoimmune diseases: a comprehensive update. J Intern Med. 2015;278:369\u201395 John Wiley & Sons, Ltd.","journal-title":"J Intern Med"},{"key":"762_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/rheumatology\/keh531","volume":"44","author":"S Stagi","year":"2005","unstructured":"Stagi S, Giani T, Simonini G, Falcini F. Thyroid function, autoimmune thyroiditis and coeliac disease in juvenile idiopathic arthritis. Rheumatology. 2005;44:517\u201320 Oxford Academic.","journal-title":"Rheumatology"},{"key":"762_CR34","first-page":"0310","volume":"31","author":"TC Robazzi","year":"2013","unstructured":"Robazzi TC, Adan LF, Pimentel K, Guimar\u00e3es I, Magalh\u00e3es Filho J, Toralles MB, et al. Autoimmune endocrine disorders and coeliac disease in children and adolescents with juvenile idiopathic arthritis and rheumatic fever. Clin Exp Rheumatol. 2013;31:0310\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"762_CR35","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"762_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3899\/jrheum.150555","volume":"43","author":"MO Chan","year":"2016","unstructured":"Chan MO, Petty RE, Guzman J. A family history of psoriasis in a first-degree relative in children with JIA: to include or exclude? J Rheumatol. 2016;43:944\u20137.","journal-title":"J Rheumatol"},{"key":"762_CR37","unstructured":"Harel L, Prais D, Uziel Y, et al. Increased prevalence of antithyroid antibodies and subclinical hypothyroidism in children with juvenile idiopathic arthritis. J Rheumatol. 2006;33(1):164-6."},{"key":"762_CR38","first-page":"565","volume":"20","author":"M Alpigiani","year":"2002","unstructured":"Alpigiani M, Cerboni M, Bertini I, D\u2019Annunzio G, Haupt R, Iester A, et al. Endocrine autoimmunity in young patients with juvenile chronic arthritis. Clin Exp Rheumatol. 2002;20:565\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"762_CR39","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/art.20292","volume":"50","author":"MB Moroldo","year":"2004","unstructured":"Moroldo MB, Chaudhari M, Shear E, Thompson SD, Glass DN, Giannini EH. Juvenile rheumatoid arthritis affected sibpairs: Extent of clinical phenotype concordance. Arthritis Rheum. 2004;50:1928\u201334 John Wiley & Sons, Ltd.","journal-title":"Arthritis Rheum"},{"key":"762_CR40","first-page":"218","volume":"19","author":"HM S\u00e4il\u00e4","year":"2001","unstructured":"S\u00e4il\u00e4 HM, Savolainen HA, Kotaniemi KM, Kaipiainen-Sepp\u00e4nen OA, Leirisalo-Repo MT, Aho KV. Juvenile idiopathic arthritis in multicase families. Clin Exp Rheumatol. 2001;19:218\u201320.","journal-title":"Clin Exp Rheumatol"},{"key":"762_CR41","unstructured":"Al-Mayouf SM, Madi SM, AlMane K, Al Jummah S. Comparison of clinical and laboratory variables in familial versus sporadic systemic onset juvenile idiopathic arthritis. J Rheumatol. 2006;33(3):597-600."},{"key":"762_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767\u201378.","journal-title":"Lancet."},{"key":"762_CR43","doi-asserted-by":"publisher","unstructured":"Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F. High prevalence of antinuclear antibodies in children with thyroid autoimmunity. J Immunol Res. 2014;2014:150239. https:\/\/doi.org\/10.1155\/2014\/150239.","DOI":"10.1155\/2014\/150239"},{"key":"762_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nri.2017.111","volume":"18","author":"JF Bach","year":"2017","unstructured":"Bach JF. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol. 2017;18:105\u201320 Nature Publishing Group.","journal-title":"Nat Rev Immunol"},{"key":"762_CR45","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3899\/jrheum.080543","volume":"36","author":"B Flat\u00f8","year":"2009","unstructured":"Flat\u00f8 B, Lien G, Smerdel-Ramoya A, Vinje O. Juvenile psoriatic arthritis: Longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis. J Rheumatol. 2009;36:642\u201350.","journal-title":"J Rheumatol"},{"key":"762_CR46","doi-asserted-by":"publisher","unstructured":"Ekelund M, Aalto K, Fasth A, et al. Psoriasis and associated variables in classification and outcome of juvenile idiopathic arthritis - an eight-year follow-up study. Pediatr Rheumatol Online J. 2017;15(1):13. Published 2017 Feb 22. https:\/\/doi.org\/10.1186\/s12969-017-0145-5.","DOI":"10.1186\/s12969-017-0145-5"},{"key":"762_CR47","first-page":"462","volume":"50","author":"E \u00dcnsal","year":"2008","unstructured":"\u00dcnsal E, \u00d6ren O, Salar K, Makay B, Abac\u0131 A, \u00d6zhan B, et al. The frequency of autoimmune thyroid disorders in juvenile idiopathic arthritis. Turk J Pediatr. 2008;50:462\u20135.","journal-title":"Turk J Pediatr"},{"key":"762_CR48","doi-asserted-by":"publisher","unstructured":"van Straalen JW, Krol RM, Giancane G, et al. Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use. Rheumatology (Oxford). 2022;61(5):2104-12. https:\/\/doi.org\/10.1093\/rheumatology\/keab678.","DOI":"10.1093\/rheumatology\/keab678"},{"key":"762_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fped.2019.00256","volume":"7","author":"M Trivedi","year":"2019","unstructured":"Trivedi M, Denton E. Asthma in children and adults\u2014what are the differences and what can they tell us about asthma? Front Pediatr. 2019;7:256 Frontiers Media SA.","journal-title":"Front Pediatr"},{"key":"762_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10067-007-0778-8","volume":"27","author":"A Zeft","year":"2008","unstructured":"Zeft A, Shear ES, Thompson SD, Glass DN, Prahalad S. Familial autoimmunity: maternal parent-of-origin effect in juvenile idiopathic arthritis. Clin Rheumatol. 2008;27:241\u20134.","journal-title":"Clin Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00762-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T07:12:00Z","timestamp":1668755520000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00762-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00762-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pharmachild and all participating centers obtained approval from their respective ethics committees and were conducted in accordance with the Declaration of Helsinki. All patients provided written informed consent\/assent based on existing national regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NR has received honoraria for consultancies or speaker bureaus from the following pharmaceutical companies in the past 3\u2009years: 2 Bridge, Amgen, AstraZeneca, Aurinia, Bayer, Brystol Myers and Squibb, Celgene, inMed, Cambridge Healthcare Research, Domain Therapeutic, EMD Serono, Glaxo Smith Kline, Idorsia, Janssen, Eli Lilly, Novartis, Pfizer, Sobi, UCB.The IRCCS Istituto Giannina Gaslini (IGG), where NR works as full-time public employee has received contributions from the following industries in the last 3\u2009years: Bristol Myers and Squibb, Eli-Lilly, F Hoffmann-La Roche, Novartis, Pfizer, Sobi. This funding has been reinvested for the research activities of the hospital in a fully independent manner, without any commitment with third parties.All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}